CASE 5.1: MERCK ACQUISITION OF MEDCO Abstract Corporate mergers and acquisitions (M&A) have become popular across the globe during the last two decades due to globalization‚ liberalization‚ technological developments‚ and competitive business environment (Fisher & Siburg‚ 2009). The synergistic gains from M&A may result from efficient management‚ economies of scale‚ profitable use of assets‚ exploitation of market power‚ and the use of complementary resources (Mitchell
Premium Pharmacology Pharmaceutical industry Pharmacy
Acquisition between Merck and Schering-Plough Introduction On March 9‚ 2009‚ Merck & Co.‚ Inc. and Schering-Plough Corporation announced that their Boards of Directors have unanimously approved a definitive merger agreement under which Merck and Schering-Plough will combine‚ under the name Merck in a stock and cash transaction. As the two companies’ combined 2008 revenues were $47 billion. The deal officially closed on November 3‚ 2009. Background of the two parties Merck & Co. (NYSE: MRK) was
Premium
business Today Merck & Co‚ Inc. is one of the most recognizable companies in the pharmaceutical industry. When asked about Merck‚ most people think that it is and always has been a US company. However‚ the company’s history can be traced all the way back to the 1600’s where it was started in Darmstadt‚ Germany. Friedrich Jacob Merck purchased a local store in 1668 where he prepared and sold medicines. The store was called “At the sign of the Angels” and would remain in the Merck family for many
Premium
CASE BASED SYNOPSIS ON HOW EXACTLY HAVE COMPUTERIZATION AND INFORMATION TECHNOLOGY LOWERED COSTS AT CHEVRON AND MERCK ? 1.1 INTRODUCTION TO COMPANIES Chevron Corporation Chevron Corporation is an American multinational energy corporation. Headquartered in San Ramon‚ California‚ and active in more than 180 countries‚ it is engaged in every aspect of the oil‚ gas‚ and geothermal energy industries‚ including exploration and production; refining‚ marketing and transport;
Premium
Merck and Company‚ Inc.: SWOT Analysis and Stakeholder Evaluation Merck and Company‚ Inc.‚ a.k.a. Merck‚ is a leading worldwide pharmaceutical company that engages in manufacturing and marketing medicines‚ animal products‚ vaccines‚ and consumer health products. As most companies‚ Merck desires to continue their success as one of the top health care innovators in the world. Conducting a SWOT analysis can give them insight into internal strengths and weaknesses as well as external opportunities
Premium Pharmaceutical industry Marketing
Merck & Co Case Analysis 1. Problem Statement – Merck & Co ‘s stock market performance had trailed that of competitors in light of the concerns that company was not able to adapt to the changes in environment where as competitors was using their aggressive marketing functional unit as their competitive edge. Company also failed to take advantage of its own market opportunities especially the outcome of aftermarket studies of drugs they launched .Company was very late in adapting to
Premium Organizational structure Marketing Product management
Merck Case Study October 14‚ 2008 Relevant Facts: Merck was one of the largest pharmaceutical companies in the world. • Merck was about to lose patent protection of two of its best selling drugs‚ which had been a significant part of their $2 billion annual sales. • Merck began putting millions of dollars into research (up to $1 billion) and within three years‚ Merck was able to discover four powerful medications. • Profits weren’t all that Merck cared about; Merck’s founder believed
Premium Pharmacology Pharmaceutical industry Pharmaceutical drug
How has Merck been able to achieve substantial returns to capital given the large costs and lengthy time to develop a new drug? Merck had a 14% increase in sales between 1997 and 1998 and 22% increase in sales from 1998 – 1999‚ and a 13% annual increase in earnings over the same period. Merck’s business strategy consists of two parts: (1) developing and marketing new drugs through internal research‚ and (2) developing partnerships with smaller biotechnology companies. Since 1995‚ Merck had launched
Premium Management Education Psychology
Pada tahun 2005‚ Clark Richard menjadi CEO Merck & Co. Sedikitnya lebih dari satu tahun kemudian‚ CEO Pfizer Inc bernama Clark Kindler Jeffrey telah bergabung dengan Merck pada tahun 1972 dan berasal dari latar belakang industri‚ sedangkan Kindler telah bergabung dengan Pfizer dari McDonald’s pada tahun 2002 sebagai konsultan hukum umum. Seperti CEO mereka‚ kedua perusahaan itu secara historis mengikuti jalur yang sangat berbeda; Merck dikenal karena keahlian penelitian‚ sedangkan Pfizer dianggap
Premium
MERCK & COMPANY INC Kady Doyle Rudy Hsieh Eunkyung Jun Joey Petrella Mastura Zaini Table of Contents 2 Overview of Merck & Co Inc. 3 Case Abstract 4 History 5 Timeline of Important Milestones 5 Vision Statement 7 Mission Statement 7 Opportunities 9 Threats 9 External Factor Evaluation (EFE) Matrix 9 CPM 11 Internal Audit 12 Strengths 13 Weaknesses 13 Financial Ratio Analysis 13 Company and Industry Performance 14 Internal Factor Evaluation (IFE)
Premium Financial ratio Pharmaceutical industry Financial ratios